Outcomes of non-myeloablative HLA-haploidentical bone marrow transplant with thiotepa and post-transplant cyclophosphamide in children and adults with severe sickle cell disease, a phase ii trial: Vanderbilt global haploidentical transplant learning collaborative (VGC²) (2020)
- Authors:
- USP affiliated authors: SIMOES, BELINDA PINTO - FMRP ; CUNHA, RENATO LUIZ GUERINO - FMRP ; COSTA, THALITA CRISTINA DE MELLO - FMRP
- Unidade: FMRP
- DOI: 10.1182/blood-2020-141771
- Subjects: TRANSPLANTE DE MEDULA ÓSSEA; HEMATOLOGIA; ANEMIA FALCIFORME
- Language: Inglês
- Imprenta:
- Publisher place: Washington
- Date published: 2020
- Source:
- Conference titles: ASH Annual Meeting and Exposition
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
KASSIM, Adetola A. et al. Outcomes of non-myeloablative HLA-haploidentical bone marrow transplant with thiotepa and post-transplant cyclophosphamide in children and adults with severe sickle cell disease, a phase ii trial: Vanderbilt global haploidentical transplant learning collaborative (VGC²). Blood. Washington: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1182/blood-2020-141771. Acesso em: 10 fev. 2026. , 2020 -
APA
Kassim, A. A., de la Fuente, J., Alahmari, A. D., Eckrich, M. J., Hanna, R., Dhedin, N., et al. (2020). Outcomes of non-myeloablative HLA-haploidentical bone marrow transplant with thiotepa and post-transplant cyclophosphamide in children and adults with severe sickle cell disease, a phase ii trial: Vanderbilt global haploidentical transplant learning collaborative (VGC²). Blood. Washington: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1182/blood-2020-141771 -
NLM
Kassim AA, de la Fuente J, Alahmari AD, Eckrich MJ, Hanna R, Dhedin N, Horn BN, Black V, Gouveia RV, Seber A, Simões BP, Costa TC de M, Cunha RLG. Outcomes of non-myeloablative HLA-haploidentical bone marrow transplant with thiotepa and post-transplant cyclophosphamide in children and adults with severe sickle cell disease, a phase ii trial: Vanderbilt global haploidentical transplant learning collaborative (VGC²) [Internet]. Blood. 2020 ; 136 5 .[citado 2026 fev. 10 ] Available from: https://doi.org/10.1182/blood-2020-141771 -
Vancouver
Kassim AA, de la Fuente J, Alahmari AD, Eckrich MJ, Hanna R, Dhedin N, Horn BN, Black V, Gouveia RV, Seber A, Simões BP, Costa TC de M, Cunha RLG. Outcomes of non-myeloablative HLA-haploidentical bone marrow transplant with thiotepa and post-transplant cyclophosphamide in children and adults with severe sickle cell disease, a phase ii trial: Vanderbilt global haploidentical transplant learning collaborative (VGC²) [Internet]. Blood. 2020 ; 136 5 .[citado 2026 fev. 10 ] Available from: https://doi.org/10.1182/blood-2020-141771 - Outcomes of non-myeloablative HLA-haploidentical bone marrow transplant with thiotepa and post-transplant cyclophosphamide in children and adults with severe sickle cell disease, a phase ii trial: Vanderbilt global haploidentical transplant learning collaborative (VGC²)
- Impact of CD34 cell dose and conditioning regimen on outcomes after haploidentical donor hematopoietic stem cell transplantation with post-transplantation cyclophosphamide for relapsed/refractory severe aplastic anemia
- Avaliação de marcadores séricos relacionados à ativação e à disfunção endotelial nos períodos pré e pós-transplante de células progenitoras hematopoéticas para tratamento da doença falciforme
- Associação prognóstica de polimorfismos gênicos da resposta imunológica em doadores e receptores de transplante não aparentado de células tronco hematopoiéticas de sangue de cordão umbilical e placentário
- The Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular seeks the implementation of, and access to, the CAR-T cell treatment in Brazil [Editorial]
- Haploidentical hematopoietic stem cell transplantation with post-transplant cyclophosphamide for severe aplastic anemia
- Blood transfusion support for sickle cell patients during haematopoietic stem cell transplantation [Carta]: a single‐institution experience
- Hematopoietic stem cell transplantation reverses white matter injury measured by diffusion-tensor imaging (DTI) in sickle cell disease patients
- Assessment of oral health condition in recipients of allogeneic hematopoietic cell transplantation
- Cryopreservation impairs engraftment in bone marrow transplantation
Informações sobre o DOI: 10.1182/blood-2020-141771 (Fonte: oaDOI API)
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 |
003121620.pdf |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
